Matthew A Cantrell
Affiliation: University of Iowa
- Intraoperative floppy iris syndrome associated with alpha1-adrenergic receptor antagonistsMatthew A Cantrell
Veterans Affairs Medical Center, Iowa City, IA 52246, USA
Ann Pharmacother 42:558-63. 2008..To describe intraoperative floppy iris syndrome (IFIS) in association with alpha(1)-adrenergic receptor (alpha(1)AR) antagonists by conducting a thorough literature review...
- Alvimopan for postoperative ileusHeather R Bream-Rouwenhorst
Pharmacy Service 119, Veterans Affairs Medical Center, 601 Highway 6 West, Iowa City, IA 52246 2208, USA
Am J Health Syst Pharm 66:1267-77. 2009..The efficacy, safety, pharmacology, pharmacokinetics, drug-drug interactions, and administration of alvimopan for postoperative ileus are reviewed...
- Silodosin for benign prostatic hyperplasiaMatthew A Cantrell
College of Pharmacy, University of Iowa Clinical Pharmacy Specialist, Veterans Affairs Medical Center, Iowa City, IA, USA
Ann Pharmacother 44:302-10. 2010..To review the pharmacology, pharmacokinetics, clinical trials, and safety of silodosin, a recently approved alpha(1A)-adrenergic receptor (AR) antagonist for benign prostatic hyperplasia (BPH)...
- Tadalafil: a phosphodiesterase-5 inhibitor for benign prostatic hyperplasiaMatthew A Cantrell
Department of Pharmacy Practice and Science, University of Iowa College of Pharmacy, Iowa City, Iowa, USA
Pharmacotherapy 33:639-49. 2013..Given the efficacy and safety data currently available, the PDE-5 inhibitor tadalafil represents a reasonable alternative for selected male patients with LUTS associated with BPH, especially with concomitant erectile dysfunction...
- Preemptive dose reduction of warfarin in patients initiating metronidazoleRyan K Holt
Department of Pharmacy Practice and Science, University of Iowa College of Pharmacy, Iowa City, IA, USA
Drug Metabol Drug Interact 25:35-9. 2010..The goal of this study was to determine if preemptive dose reduction (PDR) of warfarin is effective in maintaining therapeutic anticoagulation in patients initiating metronidazole...